INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in West Virginia. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | W. Va. Code § 16-51-1 et seq. (Ben Price Right to Try Act)“A manufacturer of an investigational drug, biological product or device may make available the manufacturer's investigational drug, biological product or device to eligible patients pursuant to this article.” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2016 | 2016 W. Va. Acts, Enrolled S.B. 416 (2016 Regular Session)“Bill History For §16-51-7 2016 Regular Session SB416 Signed Bills For §16-51-7 2016 Regular Session Enrolled Senate Bill 416” | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | require individualized approval | W. Va. Code § 16-51-3, as amended by Enr. Com. Sub. H.B. 4610 (2026), Acts 2026 ch. 183“a drug, biological product, or device that is unique and produced exclusively for use for an individual patient, based on their own genetic profile, including individualized gene therapy antisense oligonucleotides and individualized neoantigen vaccines”Note: Stored false is wrong. HB 4610 'Safeguard the Right-To-Try Cutting-Edge Medicine Act' ('relating to the right to try individualized treatments') expands eligibility to life-threatening or severely debilitating illness and adds individualized treatments to the definition. Bill history page (https://www.wvlegislature.gov/Bill_Status/bills_history.cfm?input=4610&year=2026&sessiontype=RS&btype=bill): 'Approved by Governor 4/1/2026'; 'Chapter 183, Acts, Regular Session, 2026'; effective June 12, 2026. The code site's § 16-51-3 had not yet been checked for the update. | Link | 2026-10-09 | high |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | W. Va. Code § 16-51-7“This article does not create a private cause of action against a manufacturer of an investigational drug, biological product or device ... for any harm done to the eligible patient resulting from the investigational drug”Note: Stored false is wrong. This is a 'no private cause of action' clause, not an express immunity, and it is qualified: 'so long as the manufacturer, health care provider, or other person or entity is complying in good faith with the terms of this article.' | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | W. Va. Code § 16-51-4(d)“A health insurance carrier may, but is not required by this article to, provide coverage for the cost of an investigational drug, biological product or device.” | Link | 2026-10-09 | high |
View full West Virginia profile (all layers) · Report an error on this page